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Background: There remains a need for techniques that improve the sensitive detection of viable Plasmodium
falciparum as part of diagnosis and therapeutic monitoring in clinical studies and usual-care management of
malaria infections. A non-invasive breath test based on P. falciparum-associated specific volatile organic compounds
(VOCs) could fill this gap and provide insights into parasite metabolism and pathogenicity. The aim of this study
was to determine whether VOCs are present in the headspace above in vitro P. falciparum cultures.
Methods: A novel, custom-designed apparatus was developed to enable efficient headspace sampling of infected
and non-infected cultures. Conditions were optimized to support cultures of high parasitaemia (>20%) to improve
the potential detection of parasite-specific VOCs. A number of techniques for VOC analysis were investigated
including solid phase micro-extraction using two different polarity fibres, and purge and trap/thermal desorption,
each coupled to gas chromatography–mass spectrometry. Each experiment and analysis method was performed at
least on two occasions. VOCs were identified by comparing their mass spectra against commercial mass spectral
libraries.
Results: No unique malarial-specific VOCs could be detected relative to those in the control red blood cell cultures.
This could reflect sequestration of VOCs into cell membranes and/or culture media but solvent extractions of
supernatants and cell lysates using hexane, dichloromethane and ethyl acetate also showed no obvious difference
compared to control non-parasitized cultures.
Conclusions: Future in vivo studies analysing the breath of patients with severe malaria who are harbouring a
parasite biomass that is significantly greater than achievable in vitro may yet reveal specific clinically-useful volatile
chemical biomarkers.
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The detection of viable parasite forms is an essential re-
quirement for malaria diagnosis and subsequent moni-
toring of the response to anti-malarial therapy. For
diagnosis, microscopic examination of a peripheral blood
smear remains the investigation of choice in a wide var-
iety of clinical situations. However, the sensitivity of mi-
croscopy is limited even when expert microscopists view
high quality slides. In addition, the diagnosis may be
missed in cases of severe falciparum malaria in which
the majority of parasites are sequestered within the* Correspondence: tim.davis@uwa.edu.au
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reproduction in any medium, provided the ormicrovasculature of major organs [1,2] or in the placenta
in infected expectant mothers [3,4]. Antigen detection
kits can be used where reliable microscopy is unavailable
but their accuracy for placental malaria remains in ques-
tion [5]. PCR increases diagnostic sensitivity but its
timely availability is limited largely to specialized labora-
tories in developed countries. In addition, the sensitivity
of PCR (down to 1 parasite/μL) means that even a child
weighing only 15 kg and with a circulating blood volume
of approximately 1 litre who is PCR-negative may still
harbour up to a million malaria parasites. The monitor-
ing of the response to antimalarial therapy in individual
patients depends on the availability of serial blood
smears complemented by PCR where available. Antigentd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sistence of antigen after parasite clearance, while PCR
does not differentiate between DNA from viable and
non-viable parasites [5].
There is a need for the development of alternative
diagnostic tests that detect viable parasites before and
after treatment with greater specificity and sensitivity
than currently available methods. The human breath
contains a large number of volatile organic compounds
(VOCs) derived from the blood by passive diffusion in
the lungs [6]. VOCs in the breath are directly related to
concentrations in blood and other tissues as they flow
from compartments with higher vapour pressure to
those with lower pressure [6]. Breath tests have been
used to assist in the early diagnosis of conditions such as
heart disease, rheumatoid arthritis and lung cancer [7-9]
as they detect increased VOCs released as a result of
disease-specific cellular injury. More recently, exogenous
VOCs produced by microorganisms such as Mycobacter-
ium tuberculosis have been found in the breath of
infected patients [10]. Plasmodium species may, in the
same way, produce a characteristic VOCs ‘fingerprint’
that can facilitate diagnosis and therapeutic monitoring.
In the case of Plasmodium falciparum and perhaps
Plasmodium vivax [11], the cytoadherence of mature
parasite forms in the pulmonary microvasculature may
facilitate detection of Plasmodium-specific VOCs in
breath samples. The cause of altered consciousness in
severe malaria remains unknown. VOCs are used as gen-
eral anaesthetics in clinical practice [12] and it is pos-
sible that coma complicating malaria may result from
elaboration of VOCs by malaria parasites in the cerebral
microcirculation that have anaesthetic properties. In any
case, malaria may, through indirect pathogenic tissue
effects such as oxidative stress, alter the VOCs content
of human breath in ways that are characteristic of the
infection.
A number of extraction techniques are used for the
capture and analysis of VOCs from human breath and
the microbial culture atmosphere [13-17]. Sampling and
sample preparation usually involve pre-concentrating
the analytes of interest by purge and trap, headspace,
liquid-liquid or solid phase extractions. These conven-
tional techniques consist of multiple labour-intensive
procedures and/or require organic solvents. Solid phase
micro-extraction (SPME) is an adsorption/desorption
technique that circumvents most of the drawbacks to
sample preparation [17]. SPME can be used to concen-
trate volatile and non-volatile compounds in liquid
samples or headspace without the use of solvents. The
target compounds are subsequently separated and
quantified by gas chromatography–mass spectrometry
(GC-MS) with sensitivities down to parts per trillion
levels [17].The present study outlines the design and optimization
of a P. falciparum culture-sampling system suitable for
VOCs headspace capture and analysis. The VOCs emit-
ted by P. falciparum in vitro as detected using GC-MS




The laboratory-adapted P. falciparum strains 3D7
(chloroquine-sensitive) and W2mef (chloroquine-resistant)
were maintained in RPMI 1640 HEPES (Sigma Aldrich,
St Louis, MO) supplemented with 92.6 mg/L L-glutamine
(Sigma Aldrich) 500 μg/L gentamicin, 50 mg/L hypo-
xanthine (Sigma Aldrich) and 10% v/v pooled human
plasma as previously described [18,19]. Once the para-
sitaemia was >5%, synchronous cultures at the tropho-
zoite stage were transferred into custom-designed
containers (Figure 1) at 1% haematocrit and purged
with a mixture of 1% O2 and 5% CO2 in nitrogen at
5 psi for 4 sec and 30 sec for prototypes 1 and 2, re-
spectively. Subsequent optimization used 5% O2 and 5%
CO2 in nitrogen at 15 psi for 40 sec in the prototype 2
culture-sampling apparatus. The volume of media
required to sustain high parasitaemia was calculated
using the formula: volume of media (mL)/24 hr= 0.005 x
(μL RBC pellet) x (% parasitaemia) [20]. This equation
takes into account the nutrient requirements for non-
parasitized as well as parasitized RBC. A control was set
up with non-infected RBC using similar conditions and
incubated for 24 hr at 37°C.
Solid phase micro-extraction
Volatile and semi-volatile compounds within the headspace
of non-parasitized control and malaria cultures were pre-
concentrated onto a SPME fibre coated with either polydi-
methylsiloxane (PDMS, 100 μM, #504823, SUPELCO,
Bellefonte, PA, USA) or 50/30 μM Divinylbenzene/
Carboxen/PDMS (triple fibre, #57328-U, SUPELCO,
Bellefonte, PA, USA). The fibres were conditioned ini-
tially according to the manufacturer’s instructions
(PDMS phase 250°C for 0.5 hr and triple fibre phase
270°C for 1 hr). Before each analysis, the fibre was acti-
vated in the injector port of the gas chromatograph (GC)
at 250°C for 5 min and repeated after each sampling. The
SPME fibre was introduced into the headspace of the
container by gently pushing the protective needle
through the septum that sealed the sample container.
The plunger was lowered to expose the adsorbent fibre
to the gaseous phase for one hour at 35°C. During this
time, equilibrium between the atmosphere and the fibre
was achieved, and the volatile and semi-volatile organic
compounds were adsorbed onto the coating of the fibre.
After sampling was completed, the fibre was retracted
Figure 1 Prototype 1 culture-capture apparatus with SPME is shown in panel A. The prototype 1 design consisted of a 250 mL conical flask
modified with a B-40 joint that served as a receptacle for an aluminium stopper. A delrin polymer SPME holder was screwed into the aluminium
stopper and a syringe piercable polytetrafluoroethylene (PTFE) septum was placed between the mating surfaces to seal the sample before
analysis. Design and dimensions of culture container (prototype 2) for headspace capture are shown in panel B. The wide-base (154 cm2) and
shallow design maximizes culture efficiency and total parasite yield. The B-24 joint allows for easy access during RPMI addition and parasite
sampling. Two side inlets facilitate the ease of low-oxygen gas-replacement and act as an access point for ‘purge and trap’ procedures and SPME
of the headspace atmosphere.
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into the GC injector port where VOCs were desorbed for
5 min in splitless mode at 250°C.
Solvent extraction
Supernatants from 3D7 and W2mef cultures at high para-
sitaemia (5% to 13.2%) were pooled (100 mL and 150 mL,
respectively). Cell pellets of each strain were lysed by son-
ication (Microson™ ultrasonic cell disruptor, Misonix Inc,
NY) for 30 sec and diluted with distilled water prior to
extraction. The aqueous supernatant was transferred into
a separation funnel and partitioned 3 times with 1/3 vol-
ume of an organic solvent (hexane, dichloromethane or
ethyl acetate). The procedure involved swirl-mixing with
occasional depressurization via the outlet valve of the
funnel. After the separation of aqueous and organic
phases, the organic phase was back extracted against dis-
tilled water and collected into a conical flask followed by
drying over anhydrous magnesium sulphate. After filtra-
tion (Whatman™ No. 1 filter paper), the solvent wasevaporated under reduced pressure by means of a rotary
evaporator (Rotavapor-R, Buchi Labortechnik, Flawil,
Switzerland). For analysis by GC-MS, concentrated
extracts were evaporated to dryness under a stream of
nitrogen gas and resuspended in 100 μL of the extrac-
tion solvent.
Purge and trap/ thermal desorption
For purge and trap extraction, non-parasitized control
and P. falciparum infected RBC were cultured in proto-
type 2 containers (Figure 1). Air was drawn through the
side inlets containing a loosely fitted cap and through
the flask over the surface of the samples and the VOCs
were trapped using a Tenax™ trap (200 mg Tenax TA
60/80, SUPELCO, Bellefonte, PA, USA). The headspace
was collected for 1 hr at an airflow rate of 1.5 L/min
using a portable air sampling pump (224-PCXR8, SKC
Inc.) The trap was inserted into a short path thermal de-
sorption injector (TD-2, Scientific Instrument Services,
Inc.) and desorbed for 5 min at 200°C using a flow of
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5973 MS) injection port that was also set at 200°C. The
desorbed VOCs were collected on the column during
the desorption process by cooling a small section of the
capillary column with an ethanol/dry ice bath (−20°C to
−40°C). The column was then equilibrated to 35°C and
the temperature program on the GC-MS was started.
The compounds were separated using a 30 m× 0.25 mm
i.d., 0.25 μm BPX-5 column (SGE), which was set at 35°C
for 2 min and increased at 7°C/min until 250°C, and held
for 10 min. The mass spectrometer was set to record
between 45 and 400 amu.
Gas chromatography and mass spectrometry
SPME and solvent extracted samples were analysed
using GC-MS (Shimadzu GCMS-QP2010, Kyoto, Japan).
The separation of emitted components was achieved
using a 30 m× 0.25 mm i.d., 0.1 μm Rt-Stabilwax
(Restek, Bellefonte, PA) column with ultra-high purity
helium as the carrier gas at a constant flow rate of
1 mL/min. Samples were injected in splitless injection
mode with the inlet temperature set to 250°C. The initial
oven temperature was set at 35°C and held for 5 min
then ramped at 7°C/min to 250°C and held for 10 mins.
The desorption time for SPME was 5 min, while for
solvent injections 1 μL was injected. The ion source was
set at 200°C, and the spectrometer was set to record be-
tween 45 and 400 amu [21].
Data analysis
Headspace and supernatant extractions were performed
in at least two independent culture-experiments. Data
collection and mass spectra generation were performed
using the GC-MS Real Time Analysis software and Post-
run application (GCMS solution, version 2.40 Shimadzu
Corporation) respectively. For compound identification,
mass spectra of the target molecule were screened
manually with background subtraction against commer-
cial mass spectral libraries (NIST05, NIST05s, Standard
Reference Data Program, Gaithersburg, MD). The VOCs
profiles were compared in detail for any unique com-
pounds by utilising the data comparison function in the
Postrun software. The top 30 peaks with tentative com-
pound assignment (> 95% similarity) and relative inten-
sities from P. falciparum cultures and non-infected
erythrocytes are reported.
Results
Malaria VOCs assay development
Design of culture-VOC capture apparatus
Preliminary studies employed T25 flasks coupled with a
rubber stopper with two inlets for the culture and cap-
ture of headspace atmosphere (Skinner-Adams T, data
unpublished). However, the use of plastic containers andrubber introduces organic contaminants which may
interfere with the assay. Therefore, custom-designed
glass flasks were created for the in vitro capture of head-
space VOC experiments.
The prototype 1 sampling unit for VOCs analysis is
shown in Figure 1A. The flask size allowed the culture of
up to a maximum of 18 mL of parasite-cell-medium sus-
pension. To increase parasite mass and VOCs yield, a sec-
ond design was proposed featuring a shallow container
with a large base-area (Figure 1B). The prototype 2 sam-
pling units were custom-made and equipped with two
Duran screw thread tube connections (GL14, Vel, Leuven,
Belgium) useful for purge and trap, and SPME sampling.
A B-24 joint with a fitted glass stopper improved access to
the parasite cultures and changing of media. This was par-
ticularly important during the optimization phase of the
study in which parasite growth was monitored daily by
microscopic examination of blood smears. The new de-
sign allowed a larger volume set-up (50 mL) of parasite-
cell-media suspension. Cultures of high parasitaemia
(>20%) were achieved under the conditions specified
above with increased air/medium contact surface available
for gas-exchange in the new design.
Optimization of culture conditions
Headspace capture of VOCs requires an enclosed culture
system, where the atmosphere within the culture con-
tainer must be optimized for parasite growth. The gas
mixture of 1% O2 and 5% CO2 in nitrogen used for rou-
tine cultures (i.e. in a 28.4 L Nalgene dessicator) was sub-
optimal to sustain P. falciparum growth in the present
custom-designed containers. On macroscopic examin-
ation, RBC became much darker after incubation, likely
attributable to inadequate oxygenation. A series of down-
sized, volume vs duration of gas injection experiments
were conducted with an oxygen monitor to determine
optimal gas balance. Optimal conditions for normal para-
site replication using prototype 2 were achieved with a
new gas mixture of 5% O2, and 5% CO2 in nitrogen [22].
Routine in vitro culture of P. falciparum usually main-
tains a maximum of 5% parasitaemia at 5% haematocrit.
Prototype 2 container was more suitable for malaria cul-
ture than its predecessor. The initial period for VOCs
capture was over 48 hr (i.e. one parasite life cycle), how-
ever, the system must remain closed during this time
without the required media changes. This approach pro-
duced stressed parasites as indicated by the presence of
gametocytes by microscopy. Therefore, subsequent cap-
ture experiments were set up over the later 24 hr of the
developmental cycle where there is maximal parasite
metabolic activity. Synchronized P. falciparum were cul-
tured at high parasitaemia and pooled into prototype 2
containers at the trophozoite stage (>20% parasitaemia at
1% haematocrit). To promote liberation of VOCs from
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tainers were incubated in a shaking incubator at slow ro-
tation (40 rpm) for 24 hr.
Analysis of volatile organic compounds
This part of the present study employed a number of ex-
traction approaches to capture and analyse VOCs from
the culture samples. Headspace VOCs were extracted by
SPME (PDMS and combined Carboxen/DVB/PDMS
phases – termed triple fibre) and purge and trap coupled
with thermal desorption. Direct immersion of the SPME
fibre, and traditional extractions with organic solvents
with various polarities were used to extract VOCs
trapped in the culture supernatant and cell lysate matrix.
Overall, mass spectra of over 100 different compounds
were detected in the headspace, supernatant and cell
lysates of both non-parasitized control and P. falciparum
cultures. A number of hydrocarbons such as alkanes and
alkenes, alcohols, benzene-derivatives and mono-
terpenes were identified in both parasitized and control
samples (see Figure 2). Table 1 presents the top 30 com-
pounds detected in the samples and relative quantities
using the combined triple fibre SPME, which appeared
to give the most sensitive results in our experiments. Al-
though minor differences in compound quantities were
detected, no unique biomarker for P. falciparum was
identified, despite detailed comparison of the data files.
Similarities between VOCs liberated from non-parasitized
control and infected samples were seen using other extrac-
tion methods.
Discussion
Despite a number of attempts following a step-wise ap-
proach, the present in vitro study revealed no specificFigure 2 Chromatograms of VOCs detected in the headspace of cultu
(triple fibre) sampling of the headspace above in vitro cultures of P. falcipar
Details of tentatively assigned compounds are presented in Table 1.patterns of VOCs released by P. falciparum cultures.
Various methods of headspace analysis as well as solvent
extraction (hexane, dichloromethane, ethylacetate) of
supernatants and cell lysates were examined, but the
results showed no obvious differences between P. falcip-
arum and control non-parasitized cultures. When used
with a pre-concentration device such as SPME, GC-MS
has sufficient sensitivity in the low ppt range [23,24] to
detect such differences. Despite this sensitivity, data
from SPME using PDMS and triple fibre (PDMS+divi-
nylbenzene + carbowax) revealed the production of a var-
iety of VOCs that were derived from background red
blood cell cultures. Thermal desorption of purge and
trap samples also showed no significant differences with
a similar VOCs profile to that observed using SPME
fibres, suggesting that both techniques were detecting
the majority of released VOCs. Thus, no unique com-
pounds derived from P. falciparum were able to be iden-
tified above control levels despite a number of methods
being investigated.
Previous studies of VOCs generated by other infectious
agents have shown positive associations between VOCs
liberated in vitro and those detected in the breath from
patients. This in vitro vs in vivo relationship is exempli-
fied by studies of respiratory infections with Aspergillus
fumigatus [15,24,25] and pulmonary tuberculosis [10].
There were, however, a number of important differences
between these studies and the present series of experi-
ments. Firstly, bacterial and fungal colonies are cultured
on solid medium. Any VOCs produced by bacteria and
fungi are released directly into the culture headspace. By
contrast, P. falciparum are enveloped by two extra layers,
being within RBC that settle at the bottom of liquid
medium in the culture plate. The possibility of loss ofred P. falciparum. GC-MS total ion chromatogram derived from SPME
um infected red blood cells (top) and control red blood cells (bottom).
Table 1 Representative VOCs detected in control and P. falciparum infected cultures using SPME (triple fibre) coupled
with GC-MS (Figure 2)
Relative abundance (%)
Retention time (mins) Compound Control cultures P. falciparum-infected cultures
1.81 carbon dioxide 3539462 (1.39) 1554307 (0.62)
2.64 octane 646353 (0.25) 783376 (0.31)
3.40 2,4-dimethyl-1-heptene 623570 (0.24) 615473 (0.24)
4.14 octamethyl tetrasiloxane* 724464 (0.28) 560807 (0.22)
4.33 2,2,4,6,6-pentamethyl heptane 7031090 (2.76) 8250249 (3.28)
4.45 4-methyl nonane 609038 (0.24) 638770 (0.25)
5.22 2,6-dimethyl nonane 1740986 (0.68) 1668518 (0.66 )
5.36 decane 6616172 (2.59) 7986280 (3.18)
5.50 branched alkane (C11H24) 1452353 (0.57) 1453227 (0.58)
6.07 2,6-dimethyl decane 947057 (0.37) 1061297 (0.42)
6.17 3,7-dimethyl decane 716160 (0.28) 716355 (0.28)
6.59 toluene 1000764 (0.39) 962309 (0.38)
6.70 branched alkene (C11H22) 1145337 (0.45) 1218163 (0.48)
6.92 unidentified siloxane* 2167416 (0.85) 3703832 (1.47)
7.44 dodecane 983881 (0.39) 1189196 (0.47)
7.82 branched alkane (C12H26) 698815 (0.27) 1644428 (0.65)
8.03 branched alkene (C12H24) 2883283 (1.13) 2925879 (1.16)
8.13 branched alkene (C12H24) 2891039 (1.13) 2873277 (1.14)
9.59 alpha-pinene 516866 (0.20) 762074 (0.30)
10.17 3-heptanone 514761 (0.20) 518528 (0.21)
10.77 isopropyl benzene 404573 (0.16) 498258 (0.20)
11.36 unidentified alkane 910196 (0.36) 725047 (0.29)
11.57 D-limonene 451954 (0.18) 398652 (0.16)
13.22 2-pentyl furan 979481 (0.38) 1209153 (0.48)
15.28 cyclohexanone 3714649 (1.46) 4124560 (1.64)
19.66 cyclohexanol 558229 (0.22) 682196 (0.27)
20.49 1,3-di-tert-butylbenzene 10159046 (3.98) 7908796 (3.15)
21.28 1-octen-3-ol 796995 (0.31) 1909838 (0.76)
22.56 2-ethyl-1-hexanol* 198435706 (77.77) 191847968 (76.31)
23.23 unidentified alkane 1285623 (0.50) 1027694 (0.41)
*known contaminants.
Compounds were tentatively identified (> 95% similarity) by comparing the experimental mass spectra obtained with known compounds present in a commercial
library of mass spectra (NIST05).
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ture medium prompted repeated extractions of super-
natant and cell lysate using various organic solvents. No
obvious differences between malaria and control cultures
were found in these experiments.
Secondly, the biomass of bacteria and fungi in vitro
assessed from colony-forming units (cfu), viable bacter-
ial or fungal cells per visible colony is much greater
than that of P. falciparum in a typical culture. The
number of cfu per visible colony is substantially higher
than the number of malaria parasites in a comparablevolume of RBC. For Mycobacterium tuberculosis cul-
ture, an inoculum of 0.5 mL of a 1.0 McFarland stand-
ard contains 1.5 x 108 cfu) [10] compared to a 50 mL
P. falciparum culture of 20% parasitaemia at 1% haem-
atocrit which contains approximately 1.1 x 107 parasi-
tized cells. In addition, the greater biomass for bacteria
housed within a smaller culture vessel (1 mL head-
space) considerably increases the concentration and
thus likelihood of VOCs detection compared with the
larger headspace (500 mL) of an intra-erythrocytic
parasite culture.
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cultures presented a substantial challenge because of the
fastidious nature of P. falciparum in culture, including
microaerophilic requirements, daily medium changes
and the need for a closed-system for headspace capture.
Although the use of glass culture-capture apparatus
minimized the presence of contaminants related to the
use of plastics, a number of external VOCs were present.
Compounds such as 2-ethyl-1-hexanol (Table 1) may
have been derived from bis-2-ethyl-hexyl-phthalate, a
common additive to plastics which renders the plastic
more flexible [26]. Siloxane derivatives were also present
and were derived either from the PDMS coating of the
SPME fibre, the GC column stationary phase or silicon
septa used to seal the GC injection port.
A number of different gas mixtures have been used to
support malaria culture. Atmospheres with combinations
of 0.5 to 21% O2 mixed with 1 to 7% CO2 diluted in ni-
trogen and microbial gas sachets have been employed
[20,27-30]. High oxygen concentrations are considered
to cause deleterious effects on parasites and reduce yields
[31], however this has been debated [20]. A mixture of
5% O2 with 5% CO2 in nitrogen supports malaria growth
better than 5% CO2 with 95% air [32], although both
mixtures have been successful [20,28,30,33,34]. There-
fore, although gas composition is an important consider-
ation, it should not be singled out as the determining
factor for successful cultures, particularly for high parasi-
taemias. In addition to the use of premixed gas, the tran-
sition from 5% haematocrit for routine P. falciparum
culture to a lower haematocrit (1%) proved an important
modification to support high parasitaemia for the VOCs
experiments. An appropriate ratio of medium to cell pel-
let volume prevents parasite toxicity and helps maintain
viability [20].
Although VOCs may be more readily detected in vivo
in respiratory diseases [7,23,25,35], VOCs generated as
part of host response to a systemic disease may also
serve as biomarkers. Examples include increased produc-
tion of pentane and carbon disulfide in the breath of
patients with schizophrenia [36]. Nevertheless, their spe-
cificity remains questionable, as breath carbon disulfide
has been detected in both smokers and non-smokers
[37] and has been linked with myocardial infarction [9].
An assessment of a characteristic VOCs fingerprint in
the context of malaria (including severe and non-severe
cases) in vivo was beyond the scope of the present
in vitro experiments reported in this study.
Conclusions
The present study used optimized experimental condi-
tions to enable the capture, extraction and analysis of
VOCs liberated from P. falciparum cultures. Even at
high parasitaemia (~20%), VOCs unique to P. falciparumcultures were not detected using solvent extraction,
purge and trap-thermal desorption, or SPME. GC-MS
data revealed a variety of VOCs but no unique malarial
finger-prints. Future in vivo studies analysing the breath
of patients with severe malaria may yet reveal specific
clinically-useful volatile biomarkers. A child weighing
15 kg with a circulating blood volume of 1 litre sustain-
ing a low 0.2% parasitaemia will, for example, harbour
up to 1 x 1010 parasites vs only 1.1 x 107 parasites in our
in vitro system. Notwithstanding the complex kinetics
governing VOCs in expired air from such a patient, it is
possible that the greater in vivo biomass may improve
the sensitivity of subsequent detection of VOCs from
breath samples relative to that achieved in our in vitro
experiments. In addition, specific VOCs may be gener-
ated in vivo in response to the infection.
Abbreviations
GC-MS: Gas chromatography–mass spectrometry;
PDMS: Polydimethylsiloxane; RBC: Red blood cells; SPME: Solid phase
micro-extraction; VOCs: Volatile organic compounds.
Competing interests
The author(s) declare that they have no competing interests.
Authors’ contributions
RW participated in study design, experimentation, data analysis and drafted
the manuscript. GF participated in study design, GC-MS optimization, data
analysis and critical revision of the manuscript. TD conceived the study, and
participated in its design and coordination, and critical revision of the
manuscript. All authors read and approved the final manuscript.
Acknowledgments
We would like to thank Sarah Davis for fabricating the glassware used in this
study and Andrew Sawyer for machining the Aluminium and Delrin
components. GRF is supported by the Australian Research Council
(DP0880484) and TMED is the recipient of a National Health and Medical
Research Council Practitioner Fellowship.
Author details
1University of Western Australia, School of Medicine and Pharmacology,
Fremantle Hospital, PO Box 480, Fremantle, WA 6959, Australia. 2University of
Western Australia, School of Chemistry and Biochemistry, Nedlands, WA,
Australia.
Received: 9 June 2012 Accepted: 4 September 2012
Published: 7 September 2012
References
1. Coltel N, Combes V, Hunt NH, Grau GE: Cerebral malaria - a neurovascular
pathology with many riddles still to be solved. Curr Neurovasc Res 2004,
1:91–110.
2. Safeukui I, Correas JM, Brousse V, Hirt D, Deplaine G, Mule S, Lesurtel M,
Goasguen N, Sauvanet A, Couvelard A, Kerneis S, Khun H, Vigan-Womas I,
Ottone C, Molina TJ, Treluyer JM, Mercereau-Puijalon O, Milon G, David PH,
Buffet PA: Retention of Plasmodium falciparum ring-infected erythrocytes
in the slow, open microcirculation of the human spleen. Blood 2008,
112:2520–2528.
3. Duffy PE: Plasmodium in the placenta: parasites, parity, protection,
prevention and possibly preeclampsia. Parasitology 2007, 134:1877–1881.
4. Goyal A, Goel S, Gowda DC: Plasmodium falciparum: Assessment of
parasite-infected red blood cell binding to placental chondroitin
proteoglycan and bovine tracheal chondroitin sulfate A. Exp Parasitol
2009, 123:105–110.
5. Kattenberg JH, Ochodo EA, Boer KR, Schallig HD, Mens PF, Leeflang MM:
Systematic review and meta-analysis: rapid diagnostic tests versus
Wong et al. Malaria Journal 2012, 11:314 Page 8 of 8
http://www.malariajournal.com/content/11/1/314placental histology, microscopy and PCR for malaria in pregnant
women. Malar J 2011, 10:321.
6. Phillips M, Greenberg J: Ion-trap detection of volatile organic compounds
in alveolar breath. Clin Chem 1992, 38:60–65.
7. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ: Volatile
organic compounds in exhaled air from patients with lung cancer. Clin
Chem 1985, 31:1278–1282.
8. Humad S, Zarling E, Clapper M, Skosey JL: Breath pentane excretion as a
marker of disease activity in rheumatoid arthritis. Free Radic Res Commun
1988, 5:101–106.
9. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL: High breath
pentane concentrations during acute myocardial infarction. Lancet 1991,
337:933–935.
10. Phillips M, Cataneo RN, Condos R, Ring Erickson GA, Greenberg J, La
Bombardi V, Munawar MI, Tietje O: Volatile biomarkers of pulmonary
tuberculosis in the breath. Tuberculosis (Edinb) 2007, 87:44–52.
11. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire
GP: Lung injury in vivax malaria: pathophysiological evidence for
pulmonary vascular sequestration and posttreatment alveolar-capillary
inflammation. J Infect Dis 2007, 195:589–596.
12. Soukup J, Scharff K, Kubosch K, Pohl C, Bomplitz M, Kompardt J: State of
the art: sedation concepts with volatile anesthetics in critically Ill
patients. J Crit Care 2009, 24:535–544.
13. Phillips M: Method for the collection and assay of volatile organic
compounds in breath. Anal Biochem 1997, 247:272–278.
14. Lechner M, Fille M, Hausdorfer J, Dierich MP, Rieder J: Diagnosis of bacteria
in vitro by mass spectrometric fingerprinting:a pilot study. Curr Microbiol
2005, 51:267–269.
15. Syhre M, Scotter JM, Chambers ST: Investigation into the production of
2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens
in vitro and human breath samples. Med Mycol 2008, 46:209–215.
16. Martin AN, Farquar GR, Jones AD, Frank M: Human breath analysis:
methods for sample collection and reduction of localized background
effects. Anal Bioanal Chem 2010, 396:739–750.
17. Risticevic S, Lord H, Gorecki T, Arthur CL, Pawliszyn J: Protocol for
solid-phase microextraction method development. Nat Protoc 2010,
5:122–139.
18. Trager W: Cultivation of parasites in vitro. Am J Trop Med Hyg 1978,
27:216–222.
19. Wong RP, Salman S, Ilett KF, Siba PM, Mueller I, Davis TM: Desbutyl-
lumefantrine is a metabolite of lumefantrine with potent in vitro
antimalarial activity that may influence artemether-lumefantrine
treatment outcome. Antimicrob Agents Chemother 2011, 55:1194–1198.
20. Radfar A, Mendez D, Moneriz C, Linares M, Marin-Garcia P, Puyet A, Diez A,
Bautista JM: Synchronous culture of Plasmodium falciparum at high
parasitemia levels. Nat Protoc 2009, 4:1899–1915.
21. Flematti GR, Ghisalberti EL, Dixon KW, Trengove RD: Identification of alkyl
substituted 2 H-furo[2,3-c]pyran-2-ones as germination stimulants
present in smoke. J Agric Food Chem 2009, 57:9475–9480.
22. Mlambo G, Kumar N: A modified Plasmodium falciparum growth
inhibition assay (GIA) to assess activity of plasma from malaria endemic
areas. Exp Parasitol 2007, 115:211–214.
23. Chambers ST, Syhre M, Murdoch DR, McCartin F, Epton MJ: Detection of
2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med
Mycol 2009, 47:468–476.
24. Chambers ST, Bhandari S, Scott-Thomas A, Syhre M: Novel diagnostics:
progress toward a breath test for invasive Aspergillus fumigatus. Med
Mycol 2010, 49(Suppl 1):S54–S61.
25. Preti G, Thaler E, Hanson CW, Troy M, Eades J, Gelperin A: Volatile
compounds characteristic of sinus-related bacteria and infected sinus
mucus: analysis by solid-phase microextraction and gas
chromatography–mass spectrometry. J Chromatogr B Analyt Technol
Biomed Life Sci 2009, 877:2011–2018.
26. Roth B, Herkenrath P, Lehmann HJ, Ohles HD, Homig HJ, Benz-Bohm G,
Kreuder J, Younossi-Hartenstein A: Di-(2-ethylhexyl)-phthalate as plasticizer
in PVC respiratory tubing systems: indications of hazardous effects on
pulmonary function in mechanically ventilated, preterm infants. Eur J
Pediatr 1988, 147:41–46.
27. Trager W, Jensen JB: Human malaria parasites in continuous culture.
Science 1976, 193:673–675.28. Mirovsky P: Continuous culture of Plasmodium falciparum asexual stages
in "normal" air atmosphere. Folia Parasitol (Praha) 1989, 36:107–112.
29. Taylor-Robinson AW: Cultivation of Plasmodium falciparum in vitro using
microbiological gas sachets that generate microaerophilic conditions.
Trans R Soc Trop Med Hyg 1998, 92:357–358.
30. Onda T, Lin Q, Kano S, Suzuki M: Continuous in vitro culture of
Plasmodium falciparum using microaerophilic gas generators and
portable incubator. Kansenshogaku Zasshi 1999, 73:1095–1098.
31. Scheibel LW, Ashton SH, Trager W: Plasmodium falciparum:
microaerophilic requirements in human red blood cells. Exp Parasitol
1979, 47:410–418.
32. Cohen S, Butcher GA, Crandall RB: Action of malarial antibody in vitro.
Nature 1969, 223:368–371.
33. Miyagami T, Waki S: In vitro cultivation of Plasmodium falciparum under
aerobic atmosphere in a CO2 incubator. J Parasitol 1985, 71:262–263.
34. Flores MV, Berger-Eiszele SM, Stewart TS: Long-term cultivation of
Plasmodium falciparum in media with commercial non-serum
supplements. Parasitol Res 1997, 83:734–736.
35. Chapman EA, Thomas PS, Yates DH: Breath analysis in asbestos-related
disorders: a review of the literature and potential future applications.
J Breath Res 2010, 4:034001.
36. Phillips M, Sabas M, Greenberg J: Increased pentane and carbon disulfide
in the breath of patients with schizophrenia. J Clin Pathol 1993,
46:861–864.
37. Phillips M: Detection of carbon disulfide in breath and air: a possible new
risk factor for coronary artery disease. Int Arch Occup Environ Health 1992,
64:119–123.
doi:10.1186/1475-2875-11-314
Cite this article as: Wong et al.: Investigation of volatile organic
biomarkers derived from Plasmodium falciparum in vitro. Malaria Journal
2012 11:314.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
